298 related articles for article (PubMed ID: 17405859)
21. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
[TBL] [Abstract][Full Text] [Related]
22. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of the interaction of neuropilin-1 with heparin and a heparan sulfate mimetic library of heparin-derived sugars.
Uniewicz KA; Ori A; Ahmed YA; Yates EA; Fernig DG
PeerJ; 2014; 2():e461. PubMed ID: 25024924
[TBL] [Abstract][Full Text] [Related]
24. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.
Jaalouk DE; Ozawa MG; Sun J; Lahdenranta J; Schlingemann RO; Pasqualini R; Arap W
Cancer Res; 2007 Oct; 67(20):9623-9. PubMed ID: 17942890
[TBL] [Abstract][Full Text] [Related]
25. Pharmacological inhibition of PDGF-C/neuropilin-1 interaction: A novel strategy to reduce melanoma metastatic potential.
Ceci C; Ruffini F; Falconi M; Grazia Atzori M; Falzon A; Lozzi F; Iacovelli F; D'Atri S; Graziani G; Miguel Lacal P
Biomed Pharmacother; 2024 Jul; 176():116766. PubMed ID: 38788599
[TBL] [Abstract][Full Text] [Related]
26. Structural basis for FGF receptor dimerization and activation.
Plotnikov AN; Schlessinger J; Hubbard SR; Mohammadi M
Cell; 1999 Sep; 98(5):641-50. PubMed ID: 10490103
[TBL] [Abstract][Full Text] [Related]
27. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies.
Thomas L; Low S; Hansen G; Bakker RA; Zippel N
J Pharmacol Exp Ther; 2023 Jun; 385(3):214-221. PubMed ID: 36997325
[TBL] [Abstract][Full Text] [Related]
28. Sequence dependence of C-end rule peptides in binding and activation of neuropilin-1 receptor.
Zanuy D; Kotla R; Nussinov R; Teesalu T; Sugahara KN; Alemán C; Haspel N
J Struct Biol; 2013 May; 182(2):78-86. PubMed ID: 23462097
[TBL] [Abstract][Full Text] [Related]
29. Peptides Derived from Vascular Endothelial Growth Factor B Show Potent Binding to Neuropilin-1.
Mota F; Yelland T; Hutton JA; Parker J; Patsiarika A; Chan AWE; O'Leary A; Fotinou C; Martin JF; Zachary IC; Djordjevic S; Frankel P; Selwood DL
Chembiochem; 2022 Jan; 23(1):e202100463. PubMed ID: 34647407
[TBL] [Abstract][Full Text] [Related]
30. Furin processing of semaphorin 3F determines its anti-angiogenic activity by regulating direct binding and competition for neuropilin.
Parker MW; Hellman LM; Xu P; Fried MG; Vander Kooi CW
Biochemistry; 2010 May; 49(19):4068-75. PubMed ID: 20387901
[TBL] [Abstract][Full Text] [Related]
31. Transmembrane domain interactions control biological functions of neuropilin-1.
Roth L; Nasarre C; Dirrig-Grosch S; Aunis D; Crémel G; Hubert P; Bagnard D
Mol Biol Cell; 2008 Feb; 19(2):646-54. PubMed ID: 18045991
[TBL] [Abstract][Full Text] [Related]
32. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
[TBL] [Abstract][Full Text] [Related]
33. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
[TBL] [Abstract][Full Text] [Related]
34. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165.
Gu C; Limberg BJ; Whitaker GB; Perman B; Leahy DJ; Rosenbaum JS; Ginty DD; Kolodkin AL
J Biol Chem; 2002 May; 277(20):18069-76. PubMed ID: 11886873
[TBL] [Abstract][Full Text] [Related]
35. Does Cysteine Rule (CysR) Complete the CendR Principle? Increase in Affinity of Peptide Ligands for NRP-1 Through the Presence of N-Terminal Cysteine.
Puszko AK; Sosnowski P; Raynaud F; Hermine O; Hopfgartner G; Lepelletier Y; Misicka A
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32183142
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal antibody against NRP-1 b1b2.
Li X; Luo F; Wang S; Ni E; Tang X; Lv H; Chen X; Chen L; Yan J
Hybridoma (Larchmt); 2011 Aug; 30(4):369-73. PubMed ID: 21851237
[TBL] [Abstract][Full Text] [Related]
37. A novel neuropilin-1-binding sequence in the human T-cell lymphotropic virus type 1 envelope glycoprotein.
Kusunoki H; Tanaka T; Kohno T; Matsuhashi K; Hosoda K; Wakamatsu K; Hamaguchi I
Biochim Biophys Acta Proteins Proteom; 2018 Apr; 1866(4):541-548. PubMed ID: 29458191
[TBL] [Abstract][Full Text] [Related]
38. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
Geretti E; Shimizu A; Klagsbrun M
Angiogenesis; 2008; 11(1):31-9. PubMed ID: 18283547
[TBL] [Abstract][Full Text] [Related]
39. Tuftsin prevents the negative immunoregulation of neuropilin-1highCD4+CD25+Regulatory T cells and improves survival rate in septic mice.
Gao YL; Yu MM; Shou ST; Yao Y; Liu YC; Wang LJ; Lu B; Chai YF
Oncotarget; 2016 Dec; 7(49):81791-81805. PubMed ID: 27835904
[TBL] [Abstract][Full Text] [Related]
40. Crystal structure of the plexin A3 intracellular region reveals an autoinhibited conformation through active site sequestration.
He H; Yang T; Terman JR; Zhang X
Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15610-5. PubMed ID: 19717441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
